HEATR4 Activators
HEATR4, a protein containing multiple HEAT repeat motifs, may be regulated through various signaling pathways within the cell. Compounds that elevate intracellular cAMP levels, such as those that directly stimulate adenylyl cyclase or act as beta-adrenergic agonists, lead to the activation of protein kinase A (PKA). PKA, in turn, is known to phosphorylate a broad range of proteins, and if HEATR4 is among its substrates, such phosphorylation events could result in conformational changes enhancing HEATR4's activity. Additionally, cAMP analogs that permeate the cell membrane can mimic this effect by directly activating PKA, suggesting a similar outcome for HEATR4. Another potential route of activation operates through the modulation of intracellular calcium levels. Calcium ionophores and channel agonists increase the concentration of cytosolic calcium, which might activate calcium/calmodulin-dependent kinases or calcineurin. These enzymes could potentially target HEATR4 for post-translational modifications, thereby increasing its functional activity.
Intracellular signaling cascades offer a variety of mechanisms to control the activity of proteins such as HEATR4. Certain small molecules are known to interact with these pathways, leading to the activation of proteins indirectly associated with them. For instance, agents that prompt the elevation of cAMP levels within cells can initiate a chain reaction that culminates in the activation of protein kinase A (PKA). Upon activation, PKA may phosphorylate a variety of targets, potentially including HEATR4. This phosphorylation can induce a functional upregulation of HEATR4, assuming that it serves as a substrate for PKA. Furthermore, molecules that inhibit phosphodiesterases indirectly sustain increased cAMP and cGMP levels, which could result in PKA or PKG activation, with downstream effects that might extend to the activation of HEATR4 through phosphorylation events.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate specific serine/threonine residues on proteins. If HEATR4 is a substrate for PKC, this phosphorylation could enhance its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels in cells. This can activate PKA or PKG respectively, which may then phosphorylate and increase the activity of HEATR4. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore for calcium, elevating intracellular Ca2+ levels. This rise in Ca2+ concentration could activate Ca2+/calmodulin-dependent protein kinases or calcineurin, which may subsequently modulate the activity of HEATR4. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic agonist, increasing cAMP levels in cells via Gs-protein coupled receptor signaling. This activation of cAMP-dependent pathways may lead to an increase in HEATR4 activity through PKA-mediated phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
As a cell-permeable cAMP analog, dibutyryl-cAMP activates PKA directly. This activation can lead to phosphorylation and subsequent activation of HEATR4 if it is a PKA substrate. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable cAMP analog, which also activates PKA. Activation of PKA could increase HEATR4 activity by phosphorylation. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is an inhibitor of the Na+/K+ ATPase, leading to increased intracellular sodium and secondary elevation of calcium levels via the Na+/Ca2+ exchanger. Elevated Ca2+ may activate pathways modulating HEATR4 activity. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Acts as a calcium channel agonist, increasing intracellular Ca2+ concentrations. Higher Ca2+ levels could activate kinases or phosphatases that modulate HEATR4 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, raising intracellular Ca2+ levels. This increase may activate calcium-dependent signaling pathways that enhance the activity of HEATR4. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
As a PKC inhibitor, chelerythrine chloride might lead to compensatory feedback mechanisms within the cell that enhance the activity of alternative pathways, potentially including those related to HEATR4 activation. | ||||||